Pesticide Factory Setup in Indonesia: Entity, Industrial Site, and Approvals

Choose the pesticide operation before choosing the applicant

Write a production description that distinguishes making the active ingredient, turning it into a finished formulation, and filling or repacking an existing product. These choices determine which facility, supplier and product records must support the application. A brand name or a plan to sell pesticides does not identify the manufacturing operation.

The current OSS KBLI 2025 pesticide classification separates KBLI 20211, manufacture of pest-control raw materials or active ingredients, from KBLI 20212, pest-control formulations. Treat these as different starting points for classifying the actual process. A classification describes an activity; it does not establish the project’s foreign-investment conditions, risk level or permission to operate.

Technical material, formulation and packaging have different evidence

Permentan 43/2019, Articles 1 and 17–18 defines pesticide production as making active ingredients and/or formulations. Its registration requirements separately recognise an active-material plant, a formulation plant and a packaging plant as domestic production facilities. A packaging-only plan still needs production-facility evidence. Do not describe repacking as ordinary trading simply because the formulation is unchanged.

For an owned plant, collect the industry permission that evidences control of the relevant domestic facility. Where the applicant cannot meet that facility-control requirement, Article 17(2) provides for cooperation with a domestic formulation or packaging factory, documented by a production-cooperation letter. That is a specific contractual route, not permission to put an unrelated factory address on the registration.

Separate the formulation owner, registration applicant, technical-material supplier and physical manufacturer in the project brief. One company may hold several roles, but the records must explain that arrangement. A foreign formulation owner appoints an Indonesian legal entity domiciled in Indonesia for the application under Article 17; the rule allows one such appointed entity. This does not turn a foreign representative office into a manufacturing company.

Specify intended use at the same time: crop protection, stored agricultural products, household use or disease-vector control. A change from agricultural claims to household claims can change the required product evidence even when the active ingredient is familiar. Keep this intended-use statement attached to the formulation and proposed Indonesian label throughout site selection and filing.

Screen the proposed active ingredients and additives before funding equipment or studies. Use Articles 8–13 and their annexes to check prohibitions, test-based hazard exclusions and restricted-use status for the exact formulation. A familiar active ingredient does not establish that every concentration, additive mixture or intended use can be registered. Keep the screening result with the supplier specification.

Fit the PT and capital plan to that operating role

Foreign investment generally uses an Indonesian-law limited liability company, or Perseroan Terbatas (PT), domiciled in Indonesia, unless legislation provides otherwise. Article 7(2) of Perpres 10/2021 establishes that legal-form rule. A PT with foreign investment is commonly described as a PT PMA. An Indonesian-owned PT is the domestic route; changing the label does not change the real ownership or the operating activity.

Resolve the shareholders, beneficial owners, directors, commissioner, authorised signatory and production role before the incorporation documents are finalised. The notarial deed and legal-entity approval establish the company. Taxpayer registration, its Business Identification Number (NIB) and the project’s industrial and product permissions perform different functions.

The baseline documents for company establishment in Indonesia should use an activity description consistent with the intended pesticide process; the company file then supplies the identity used in OSS and the product applications. Maintain the same legal name and address conventions across the deed, tax record, production contract and application signatories.

For PMA, Article 26 of BKPM Regulation 5/2025 sets a general investment value exceeding IDR 10 billion, excluding land and buildings, per five-digit activity per project location, with an industrial-products exception for the same production line. It separately sets issued and paid-up capital of at least IDR 2.5 billion per PT, subject to other legislation. Project investment and corporate paid-up capital are separate tests. Document how the actual production line and locations fit the calculation before committing capital.

These capital figures are not registration charges, a factory construction budget or an approval to use a particular chemical. Equally, the existence of a five-digit KBLI code does not prove a foreign-equity entitlement. Complete the activity-specific investment screen for the selected ownership and process; retain the result with the company’s scope rather than assuming a universal pesticide-sector percentage.

PP 28/2025 is the current risk-based business-licensing framework and replaces PP 5/2021. Enter the actual activity, project location and other requested project characteristics in Online Single Submission (OSS), then use the permissions and conditions assigned to that project. An issued NIB is an identity and registration output; do not read it as proof that every site, industrial or product condition has been satisfied.

Test the industrial site before committing to it

Reject a candidate site if the project cannot document both its legal location route and its ability to manage the proposed pesticide process. A generic warehouse lease, a corporate correspondence address and an industrial-estate offer are different pieces of evidence. None alone proves that the planned synthesis, blending, filling or chemical storage can take place there.

PP 20/2024, Article 62 makes industrial-estate location the default for industrial companies. Its exceptions are specific to geography or the stated industrial categories; the listed geographic exceptions and specified medium-industry exception still require location in an industrial allocation area (KPI). Do not assume that a small footprint, an existing building or a landlord’s assurance establishes an exception. Record the exact exception and evidence if relying on one.

Check how factory premises qualify as an Indonesian address against the production description before accepting the lease: the address used for the company must not obscure where the pesticide operation actually takes place. Obtain a site plan that identifies production, raw-material and finished-product storage, utilities, waste handling and any shared infrastructure. Treat these as diligence inputs to the applicable approval file.

Ask the estate operator for a project-specific environmental basis

For an industrial-estate tenant, Article 63 of PP 20/2024 requires detailed environmental management and monitoring plans approved by the estate operator, together with spatial-use conformity. Article 63(5) gives those detailed plans the stated environmental-approval function. Ask for the approved tenant document that actually covers the process, capacity and pollutants; the estate’s broad environmental document is not a substitute for identifying the tenant’s own obligations.

Before engineering is frozen, identify wastewater, air emissions, cleaning residues, off-specification material and contaminated packaging from the real process. Establish which streams are hazardous waste (Limbah B3) and who will store, transport or treat them. A formulation line using purchased technical material can have different waste streams from an active-ingredient synthesis plant; the environmental file should reflect the process rather than the sales description.

Permen LHK 6/2021, Articles 51–54 distinguishes hazardous-waste storage standards integrated with the NIB for SPPL activities from storage technical details included in environmental approval for AMDAL or UKL-UPL activities. Its separate technical-approval and operational-feasibility provisions apply to specified waste-management activities. Storing your own waste and treating hazardous waste are different approval questions. Identify the applicable route instead of ordering a generic “B3 permit.”

Keep spatial, environmental, building and industrial evidence as separate checks. Where building approval or a certificate of functional suitability is required, confirm that its actual use and configuration fit the plant. If estate acceptance, utilities or waste handling cannot accommodate the stated chemical process, change the layout or site before progressing the affected application; a product registration cannot repair that mismatch.

Prepare the pesticide dossier for its intended use

The pesticide dossier follows the formulation, technical material and intended-use claims. Permentan 43/2019, Articles 15–18 and 28–34 separates the trial-permission stage from permanent pesticide permission. Trial permission supports verification of quality, efficacy and safety claims; it is not a commercial launch approval. Article 28 provides permanent-permission categories for pesticides, technical materials and pesticides for export.

Build the applicant and supplier chain before testing

The administrative file includes the NIB, completed pesticide registration form, signing-authority statement, trademark evidence, applicable supply/data-access documents and manufacturing evidence. Article 17 also calls for the technical-material manufacturing licence from the competent authority in the country of origin. Obtain the actual supplier and production records, rather than assuming a distributor’s brochure proves origin or access to regulatory data.

The initial technical package under Article 18 includes a certificate of analysis from an accredited quality-testing laboratory, a technical-material chromatogram subject to the stated exceptions, and a certificate of composition from the formulation maker. Agree who will provide each item before commissioning studies. Reconcile the active ingredient, concentration, formulation type, supplier and facility against the application so that testing supports the product you actually intend to make.

Permanent pesticide applications add the applicable quality, toxicity, environmental-toxicity, efficacy and combination-product evidence under Article 30. The testing requirements and exceptions vary by product and use. Technical-material and export applications have their own Article 31 evidence route; do not copy the complete crop-protection study list into every dossier or assume export permission authorises Indonesian domestic distribution.

Household claims create a second product-file check

The agriculture regulation itself includes household and human disease-vector uses and provides Format-4 for those applications. Separately, Permenkes 11/2025, Annex sections 4 and 7 provides domestic product authorisation and good-manufacturing certification standards for Perbekalan Kesehatan Rumah Tangga (PKRT), household health supplies. Household pesticide positioning therefore requires a coordinated review of both pesticide and applicable health-sector evidence, not an automatic choice between ministries.

The domestic PKRT file calls for the relevant industry business permission, a Cara Pembuatan yang Baik (CPB) certificate for the product type, and the manufacturer–brand-owner relationship where applicable. It includes formula, production flow with quality-control stages, raw-material and finished-product evidence, packaging specifications, stability, Indonesian instructions, batch-code explanation, marking and claim support. The class 3 renewal requirements expressly cross-reference permanent pesticide-registration and approved-marking evidence; keep those records aligned where that class applies.

For the PKRT manufacturing-quality route, appoint the required technical responsible person and plan the quality system before the inspection stage. The current CPB standard specifies at least a D-3 qualification in health, engineering or science, CPB training, full-time work and no concurrent director or commissioner role, alongside its other conditions. These are PKRT requirements; do not transfer them indiscriminately to every agricultural pesticide factory.

Submit, answer corrections and retain the final decision

Use the applicable electronic licensing route with the authorised company account and signatory, completing the relevant product form and attaching legible evidence. Permentan Article 34 distinguishes Format-2 for synthetic/natural pesticides, Format-3 for specified attractant, pheromone or growth-regulator products, Format-4 for household/vector products, Format-5 for technical material and Format-6 for export. Select the form from the product scope, not from the factory’s trading name.

Retain the submission reference, uploaded versions, payment evidence where an official charge applies, and every request for clarification. Respond within the deadline in the applicable notice and regulation, correcting the source document as well as the portal field when they differ. Download the issued decision and its attachments; a submission acknowledgement or a file marked under review is not the approval.

Plan the schedule around studies, site readiness and a complete dossier. Articles 39–43 of Permentan 43/2019 include a decision period of up to 90 working days after the minister receives the relevant proposal, not a 90-day factory launch from incorporation. The permanent permission has a five-year validity and can be re-registered; pending applications cannot be used to justify commercial circulation. Keep authority decision periods distinct from preparation, testing and construction time.

Use a scope-to-evidence test before commercial release

Use the following documentary test when choosing an operating model. Start with the row that describes the physical work and add the household row if the intended use triggers it. The rows can overlap: a plant may make technical material and formulate products, while a different entity owns the brand. This is an editorial cross-check of the cited requirements, not a new official permit category.

The activity and applicant matches above derive from Permentan 43/2019, Articles 17–18, 28–34 and 45 ; the household layer derives from the current domestic PKRT and CPB standards . A missing item means the corresponding scope needs work before the release decision. Do not compensate for absent product permission by presenting more company documents, or for an unsuitable facility by presenting a product’s registration number.

Close the file with evidence that can be checked

• Match the legal entity and authorised applicant to the issued company, NIB, industrial and product records. Resolve inconsistent names, locations or signatories before relying on them.
• Match the actual operation and capacity to the site, environmental and industrial conditions. Keep the estate-approved tenant plan or other applicable environmental output, its conditions and relevant technical documents.
• Match each product to the issued registration decision, authorised uses and marking. For household products, reconcile the applicable PKRT output and CPB scope with the real manufacturer.
• Match the release record to what was made: formula, ingredient source, batch quality evidence, label and destination market. Escalate a changed supplier, formula, facility or claim for the applicable amendment assessment before relying on the old file.

Assign an owner for continuing conditions as soon as the approvals are issued. Articles 46–47 of Permentan 43/2019 require registration holders and production-facility owners to report production and circulation each semester in July and January, and require the holder to assure product quality. Add licence validity, applicable environmental monitoring, company tax obligations and investment reporting to the operating calendar according to the company’s actual obligations.

Approval evidence must match the factory and product that will operate. If the application is returned, diagnose the mismatch first: applicant authority, supplier access, plant control, intended use or study coverage. Repair the affected record and respond through the relevant process. Re-submitting the same inconsistent set under a different attachment name will not resolve the underlying evidence gap.

Choose the next commitment for your pesticide factory

For a technical-material project, settle ingredient eligibility, manufacturing evidence and the site’s process capacity before buying the production line. For a formulation project, secure the supplier/data-access chain and study plan alongside the plant design. For a packaging arrangement, establish the domestic partner’s relevant industrial evidence and the production-cooperation document before treating the facility requirement as resolved.

Freeze household and disease-vector claims early because they affect the pesticide form and the applicable PKRT file. The immediate commitment should follow the weakest supported part of your chosen model: entity and applicant authority, an acceptable site, a defensible production chain or the product dossier. Proceed to commercial release only after the issued outputs and their conditions have been reconciled with the actual plant, product and market; an NIB or a trial permission alone is insufficient.